MCK Discloses Data Breach Litigation, 15% Dividend Hike, Two Pending Acquisitions in Q2 FY2027
· The NYC Memo
McKesson's Q2 FY2027 10-Q disclosed multiple putative class action complaints filed since September 2026 alleging failure to secure consumer protected health information following a cybersecurity breach and alleged data exfiltration. The company reported $5.163 billion in opioid litigation liabilities as of September 30, 2026, down from $5.692 billion at March 31, 2026, with $496 million in payments made during the six-month period; separately, the Fourth Circuit reversed the Cabell County opioid case on October 28, 2025, remanding it to trial court.
McKesson raised its quarterly dividend from $0.82 to $0.94 per share on July 21, 2026, and announced planned acquisitions of Precision Medicine Group LLC and Spectrum Vision Partners on November 2, 2026.